AB1441 LEARNING NEEDS ASSESSMENT FOR PATIENTS WITH CANCER AND A PRE-EXISTING AUTOIMMUNE DISEASE WHO ARE CANDIDATES TO RECEIVE IMMUNE CHECKPOINT INHIBITORS

医学 类风湿性关节炎 背景(考古学) 强直性脊柱炎 疾病 易普利姆玛 内科学 癌症 银屑病 自身免疫性疾病 不利影响 银屑病性关节炎 溃疡性结肠炎 免疫学 免疫疗法 古生物学 生物
作者
María A. López-Olivo,Juan Ignacio Ruiz,G. F. Duhon,M. Altan,H. Tawbi,A. Diab,C. Bingham,C. Calabrese,R. Volk,M. Suarez-Almazor
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:81 (Suppl 1): 1826.2-1826
标识
DOI:10.1136/annrheumdis-2022-eular.2504
摘要

Background Patients with autoimmune disorders and cancer are at risk of developing immune-related adverse events (irAEs) and increasing flares of their underlying disease with immune checkpoint inhibitors (ICI) and harms and benefits must be weighed. Objectives We conducted an assessment of learning needs. Methods We interviewed 19 patients who had received an ICI and 20 physicians who provide care for these patients. We asked what do cancer patients with pre-existing autoimmune diseases need to know in order to make an informed decision about whether to receive an ICI. Results Fifty-three percent of the patients were female, median age was 62.9 (±10.9). They had rheumatoid arthritis (47.4%), psoriasis (26.3%), Crohn’s disease (10.5%), ankylosing spondylitis (5.3%), systemic lupus erythematosus (5.3%), or ulcerative colitis (5.3%). Half of the patients (52.6%) had a demonstrable disease activity of the autoimmune disease at the time of making the decision on whether to start ICI. Most (84%) of the patients had melanoma, and at the time of the interview 68.4% had completed or discontinued the ICI. Physicians were melanoma oncologists (30%), thoracic-head & neck medical oncologists (25%), rheumatologists (20%), gastroenterologists (10%), and dermatologists (15%) who treat patients with irAEs. Sixty percent were female. Key points mentioned by patients and physicians included information on probability of irAEs and flares of the autoimmune condition with discussion about severity, benefits of ICI, ICI mechanism of action in the context of the autoimmune disease, and management for flare-ups. Key topics raised only by patients included possible reasons for stopping or modifying treatment (for cancer or autoimmune disease), when to contact the provider, possibility of autoimmune disease progression or organ damage, sharing information with other providers, and lifestyle changes that can be done to help. Conclusion Although patients and physicians listed common learning points, patients also considered specific needs to increase their self-care. The information derived from this study will be used to develop a decision support tool. Disclosure of Interests None declared

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yufeng发布了新的文献求助10
刚刚
网易邮箱发布了新的文献求助10
1秒前
顺利小陈发布了新的文献求助10
2秒前
佳小佳完成签到,获得积分10
2秒前
落寞代亦完成签到,获得积分10
3秒前
4秒前
哈哈哈哈完成签到,获得积分10
5秒前
佳小佳发布了新的文献求助30
6秒前
6秒前
彭于晏应助半分青蓝采纳,获得10
6秒前
橘子石榴完成签到 ,获得积分10
6秒前
今后应助echo采纳,获得10
8秒前
chriswtr发布了新的文献求助50
10秒前
斑点发布了新的文献求助10
11秒前
木樨完成签到,获得积分10
15秒前
务实的乌冬面完成签到,获得积分20
17秒前
dbq完成签到 ,获得积分10
17秒前
19秒前
Junlei完成签到,获得积分10
19秒前
20秒前
CodeCraft应助parpate采纳,获得10
20秒前
chriswtr完成签到,获得积分10
21秒前
22秒前
22秒前
粥小周发布了新的文献求助10
23秒前
24秒前
领导范儿应助羊青丝采纳,获得10
25秒前
无聊完成签到,获得积分10
25秒前
碧蓝帅哥发布了新的文献求助10
25秒前
一木发布了新的文献求助20
26秒前
今后应助无Wen3采纳,获得10
28秒前
钰钰发布了新的文献求助10
28秒前
29秒前
单薄树叶完成签到,获得积分10
29秒前
29秒前
29秒前
30秒前
parpate发布了新的文献求助10
31秒前
FATYE发布了新的文献求助10
33秒前
echo发布了新的文献求助10
34秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3572296
求助须知:如何正确求助?哪些是违规求助? 3142501
关于积分的说明 9448015
捐赠科研通 2843973
什么是DOI,文献DOI怎么找? 1563103
邀请新用户注册赠送积分活动 731630
科研通“疑难数据库(出版商)”最低求助积分说明 718640